The potent immucillin purine nucleoside phosphorylase (PNP) inhibitors
F-DADMe-ImmH [(3S,4S)−3],
and [(3R,4R)−3] are
synthesized in seven steps. Cycloaddition to a fluoroalkene and an enzymic
resolution are the key features of the construction of the fluoropyrrolidines
11, from which the immucillins are assembled by use of a
three-component Mannich reaction. Slow-onset binding constants (Ki∗) for
[(3S,4S)−3] and
[(3R,4R)−3] with human
PNP are 0.032 and 1.82 nM, respectively. F-DADMe-ImmH
[(3S,4S)−3] exhibits
oral availability in mice at doses as low as 0.2 mg/kg.